featured research Archives
Vanderbilt to study use of plasma on LifeFlight
Oct. 29, 2013—Vanderbilt University Medical Center will participate in a national trial to see if outcomes for critically injured patients with uncontrolled bleeding can be improved by administering plasma to these patients while in flight to the hospital.
Theatre offers promise for youth with autism, Vanderbilt study finds
Oct. 22, 2013—A novel autism intervention program using theatre to teach reciprocal communication skills is improving social deficits in adolescents with the disorder that now affects an estimated one in 88 children, Vanderbilt University researchers released today in the journal Autism Research.
Frog-killing fungus paralyzes amphibian immune response
Oct. 17, 2013—A fungus that is killing frogs and other amphibians around the world releases a toxic factor that disables the amphibian immune response, Vanderbilt University investigators report Oct. 18 in the journal Science.
VU study identifies DNA changes in drug-resistant cancer cells
Sep. 12, 2013—Vanderbilt investigators have combined next-generation sequencing technologies and bioinformatics analyses to screen for genome-wide genetic mutations associated with drug resistance in a series of lung cancer cell lines.
‘Yo-yo dieting’ inflames fat tissue
Aug. 9, 2013—Gaining and losing weight during “yo-yo dieting” may contribute to an exaggerated immune response in fat tissue that increases metabolic dysfunction more than steady weight gain alone.
Vanderbilt scientists discover potential new way to treat anxiety
Aug. 5, 2013—Chemically modified inhibitors of the COX-2 enzyme relieve anxiety behaviors in mice by activating natural “endocannabinoids” without gastrointestinal side effects, Vanderbilt University scientists will report next week.
Cognitive complaints, Alzheimer’s risk studied
Aug. 1, 2013—A study of cognitive complaints in older adults showed that memory concerns from both the patient and an informant was most predictive of converting to Alzheimer’s disease or dementia within three years.
Project seeks to create ‘bioartificial’ kidney
Jul. 11, 2013—Nephrologist William Fissell IV, M.D., associate professor of Medicine and Biomedical Engineering, is intent on creating and mass-producing an implantable bioartificial kidney that can transform quality of life and prospects for survival for people with chronic kidney disease who would otherwise be forced onto dialysis.
Training program meets ‘critical need’ for earlier autism identification
Jul. 11, 2013—A three-year study that evaluated the effectiveness of a training program designed to enhance autism spectrum disorder identification and assessment within community pediatric settings was released this week in the journal Autism.
Validating maps of the brain’s resting state
Jun. 19, 2013—A team of Vanderbilt researchers has provided important validation of maps of the brain at rest that may offer insights into changes in the brain that occur in neurological and psychiatric diseases.
Vanderbilt study indicates fatigue and loss of sleep take predictable toll on baseball players over season
Jun. 4, 2013—Strike zone judgment grows worse over the course of a Major League Baseball season in a predictable way, possibly due to the effect of grueling travel schedules, disrupted sleep patterns and fatigue, a Vanderbilt University Medical Center sleep researcher has found.
Experts predict “unbanked” will face challenges getting health insurance
Jun. 3, 2013—Vanderbilt health policy expert John Graves co-authored a report that shows as many as a quarter of people eligible for subsidized health insurance under the Affordable Care Act may be shut out because they don’t have a bank account.
